Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value

Isomorphic Labs, an Alphabet Inc. company using artificial intelligence to discover drugs, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the matter.